Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-12-03FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approves a supplemental application for Fluphenazine hydrochloride from Lannett Company, Inc.
-
FDA approval · 2010-12-01FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for risperidone (RISPERDAL) from Janssen Pharmaceuticals, Inc., resulting in changes to its labe…
-
FDA approval · 2010-12-01FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC. The approval covers the supplemental su…
-
FDA approval · 2010-12-01FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2010-12-01FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for SEROQUEL XR (quetiapine) submitted by AstraZeneca Pharmaceuticals LP.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-12-01FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Saphris (asenapine) by Allergan to update its labeling, potentially reflecting an expanded or cl…
-
FDA approval · 2010-12-01FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2010-12-01FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved Janssen's supplemental application for Risperdal M-TAB (risperidone), a supplemental filing related to the M-TAB formulatio…
-
FDA approval · 2010-12-01FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for haloperidol decanoate (long-acting antipsychotic) submitted by Patriot Pharmaceuticals LLC.
-
FDA approval · 2010-12-01FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA has approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2010-12-01FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
FDA approved a supplemental application for Fanapt (iloperidone) filed by Vanda Pharmaceuticals, indicating an expansion related to its appr…
-
FDA approval · 2010-12-01FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals.
-
FDA label_change · 2010-12-01FDA Approved: ABILIFY — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for ABILIFY (aripiprazole) submitted by Otsuka America Pharmaceutical, Inc., resulting in change…
-
CLINICAL_TRIALS research · 2010-12-01Clinical Trial Update: Expanding Rapid Ascertainment Network of Schizophrenia Families in Taiwan
A clinical trial update describes expanding a rapid ascertainment network of families affected by schizophrenia in Taiwan, sponsored by Chin…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 study evaluating a long-acting injectable risperidone for schizophrenia (and schizoaffective disorder considerations in the title) h…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Polypharmacy in Clozapine-resistant Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating polypharmacy in clozapine-resistant schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-17Clinical Trial Update: Seroquel XR in Schizophrenia Relapse Prevention
A completed clinical trial evaluating Seroquel XR (quetiapine extended-release) for relapse prevention in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2010-11-09Clinical Trial Update: Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis [NA]
A completed clinical trial evaluating Acceptance and Commitment Therapy for distress following psychosis has been reported. The study, spons…
-
CLINICAL_TRIALS research · 2010-11-02Clinical Trial Update: Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia [Phase 1]
Phase 1 pharmacokinetic study of ABT-126 in stable subjects with schizophrenia has completed.
-
FDA approval · 2010-10-28FDA Approved: LATUDA — Original Application (Sumitomo Pharma America, Inc.)
The FDA approved Latuda (lurasidone hydrochloride) under NDA 200603 from Sumitomo Pharma America, marking the original approval of lurasidon…
-
CLINICAL_TRIALS trial_result · 2010-10-28Clinical Trial Update: Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning [Phase 4]
This Phase 4 trial compares brain effects of risperidone and paliperidone (Invega) using fMRI and PET imaging in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics
AstraZeneca-sponsored clinical trial update reports on subjective well-being in schizophrenia patients treated with quetiapine XR and other …
-
CLINICAL_TRIALS trial_result · 2010-10-22Clinical Trial Update: Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia [Phase 3]
Phase 3 trial comparing olanzapine pamoate depot with oral olanzapine in outpatients with schizophrenia; results were posted after completio…
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
This document reports a completed post-authorization safety study (RiSPECT) evaluating the safety and effectiveness of risperidone used in r…
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers [Phase 1]
Phase 1 trial update evaluating single and repeat doses of the investigational compound GSK729327 in healthy volunteers, with schizophrenia …